Roth Capital Forecasts Itron's Q3 Earnings (NASDAQ:ITRI)

Key Points

• Roth Capital has raised its Q3 2025 earnings per share estimate for Itron to $1.46, up from $1.30, while maintaining a "Buy" rating and a price target of $150.00.
• Itron reported a Q2 earnings per share of $1.62, surpassing the consensus estimate of $1.33, but its revenue fell slightly short of expectations at $606.76 million.
• Large institutional investors have significantly increased their stakes in Itron, with hedge funds and institutional investors now owning 96.19% of the company's stock.

Itron, Inc. (NASDAQ:ITRI - Free Report) - Analysts at Roth Capital raised their Q3 2025 earnings per share estimates for Itron in a research report issued on Friday, August 1st. Roth Capital analyst C. Moore now expects that the scientific and technical instruments company will earn $1.46 per share for the quarter, up from their prior forecast of $1.30. Roth Capital has a "Buy" rating and a $150.00 price objective on the stock. The consensus estimate for Itron's current full-year earnings is $5.33 per share. Roth Capital also issued estimates for Itron's Q4 2025 earnings at $1.43 EPS and FY2026 earnings at $6.25 EPS.

Itron (NASDAQ:ITRI - Get Free Report) last posted its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.29. Itron had a return on equity of 19.69% and a net margin of 11.05%. The business had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. During the same period in the previous year, the business earned $1.21 EPS. The business's quarterly revenue was down .4% on a year-over-year basis.

Several other analysts have also recently commented on ITRI. Guggenheim reiterated a "buy" rating and issued a $155.00 price objective (up previously from $133.00) on shares of Itron in a research note on Monday, July 14th. Johnson Rice downgraded Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. Stephens set a $130.00 target price on shares of Itron in a research report on Monday. Wall Street Zen upgraded Itron from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Finally, TD Cowen lifted their price objective on Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, June 20th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $136.25.

Itron Stock Performance

Shares of NASDAQ ITRI traded down $0.75 during mid-day trading on Monday, hitting $124.51. 357,696 shares of the company were exchanged, compared to its average volume of 597,660. Itron has a 1-year low of $90.11 and a 1-year high of $140.04. The firm has a market cap of $5.69 billion, a price-to-earnings ratio of 21.28, a price-to-earnings-growth ratio of 0.68 and a beta of 1.35. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The stock has a 50 day simple moving average of $129.15 and a 200-day simple moving average of $113.55.

Insiders Place Their Bets

In other Itron news, SVP Christopher E. Ware sold 339 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $114.95, for a total transaction of $38,968.05. Following the completion of the sale, the senior vice president directly owned 19,468 shares in the company, valued at approximately $2,237,846.60. This trade represents a 1.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP John F. Marcolini sold 3,783 shares of Itron stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $116.73, for a total value of $441,589.59. Following the sale, the senior vice president owned 21,865 shares in the company, valued at $2,552,301.45. This trade represents a 14.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,755 shares of company stock worth $1,879,397 over the last 90 days. Insiders own 1.45% of the company's stock.

Hedge Funds Weigh In On Itron

A number of institutional investors have recently added to or reduced their stakes in ITRI. Pinnacle Wealth Management Advisory Group LLC lifted its position in shares of Itron by 7.7% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 2,525 shares of the scientific and technical instruments company's stock worth $332,000 after buying an additional 180 shares in the last quarter. ZEGA Investments LLC acquired a new stake in shares of Itron during the second quarter worth $427,000. Prospera Financial Services Inc purchased a new stake in Itron in the second quarter valued at approximately $448,000. Penserra Capital Management LLC acquired a new stake in Itron during the second quarter valued at $203,000. Finally, Vestmark Advisory Solutions Inc. purchased a new stake in Itron during the 2nd quarter valued at about $1,145,000. Institutional investors own 96.19% of the company's stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.